Impact of an Educational Deprescribing Intervention on Provider Confidence, Knowledge and Polypharmacy in the Nursing Home Setting DOI

Julianne Murthi,

Molly Langford,

Lisa Abdallah

et al.

Journal of Hospice and Palliative Nursing, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 14, 2024

Polypharmacy is commonly encountered by providers caring for patients with medically complex and palliative care needs in many settings. The purpose of this quality improvement project was to measure the impact an evidence-based educational deprescribing intervention on polypharmacy rate provider confidence knowledge nursing home. We invited working 52 homes attend a 1-hour-long session. Twenty-one nurse practitioners 1 physician assistant across 11 states participated intervention. Provider level related improved all categories, statistical significance demonstrated both paired t test Wilcoxon signed rank ( P < .001). 3 months after decreased more centers where had attended training. Additional open-ended data about experiences barriers were collected analyzed. findings from demonstrate that focused practicing home setting can improve reduce rates. These may be used implement similar education programs nurses prioritize goals living serious illness.

Language: Английский

Features of pharmacotherapy of vascular cognitive impairment in elderly and senile patients DOI
А Н Боголепова, É. A. Mkhitaryan

Russian Journal of Geriatric Medicine, Journal Year: 2024, Volume and Issue: 2, P. 124 - 132

Published: June 30, 2024

Introduction. The problem of safe pharmacotherapy for vascular cognitive impairment (VCI) in patients aged 60 and over is a leading one due to the increasing life expectancy population. VCI associated with cerebrovascular diseases common among geriatric syndromes. Due multimorbidity, “silver age” often experience polypharmacy, which can lead decreased activity daily life, side effects adverse drug interactions. Additionally, age-related involutive processes older require dosages constant monitoring vital signs laboratory findings. Therefore, it important use drugs favorable safety profile good tolerability oldest-old real clinical practice. A review results multicenter, double-blind, placebo-controlled, randomized trials on Prospekta treatment confirmed absence significant differences number events (AEs) serious AEs when taking placebo. No clinically deviations were found parameters, nor there any negative signs, no interactions other basic therapies have been recorded Prospekta. Conclusion: be recommended practice without risk impact

Language: Английский

Citations

0

Impact of an Educational Deprescribing Intervention on Provider Confidence, Knowledge and Polypharmacy in the Nursing Home Setting DOI

Julianne Murthi,

Molly Langford,

Lisa Abdallah

et al.

Journal of Hospice and Palliative Nursing, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 14, 2024

Polypharmacy is commonly encountered by providers caring for patients with medically complex and palliative care needs in many settings. The purpose of this quality improvement project was to measure the impact an evidence-based educational deprescribing intervention on polypharmacy rate provider confidence knowledge nursing home. We invited working 52 homes attend a 1-hour-long session. Twenty-one nurse practitioners 1 physician assistant across 11 states participated intervention. Provider level related improved all categories, statistical significance demonstrated both paired t test Wilcoxon signed rank ( P < .001). 3 months after decreased more centers where had attended training. Additional open-ended data about experiences barriers were collected analyzed. findings from demonstrate that focused practicing home setting can improve reduce rates. These may be used implement similar education programs nurses prioritize goals living serious illness.

Language: Английский

Citations

0